141 related articles for article (PubMed ID: 38330918)
21. Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study.
Petta S; Eslam M; Valenti L; Bugianesi E; Barbara M; Cammà C; Porzio M; Rosso C; Fargion S; George J; Craxì A
Liver Int; 2017 Sep; 37(9):1389-1396. PubMed ID: 28235154
[TBL] [Abstract][Full Text] [Related]
22. Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity.
Zhou X; Lin X; Chen J; Pu J; Wu W; Wu Z; Lin H; Huang K; Zhang L; Dai Y; Ni Y; Dong G; Fu J
Front Endocrinol (Lausanne); 2022; 13():986841. PubMed ID: 36120457
[TBL] [Abstract][Full Text] [Related]
23. Origin of cardiovascular risk in overweight preschool children: a cohort study of cardiometabolic risk factors at the onset of obesity.
Shashaj B; Bedogni G; Graziani MP; Tozzi AE; DiCorpo ML; Morano D; Tacconi L; Veronelli P; Contoli B; Manco M
JAMA Pediatr; 2014 Oct; 168(10):917-24. PubMed ID: 25111132
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Childhood Obesity or Sarcopenic Obesity on Metabolic Syndrome Risk in Adolescence: The Ewha Birth and Growth Study.
Park H; Jun S; Lee HA; Kim HS; Hong YS; Park H
Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677058
[TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study.
Semmler G; Wernly S; Bachmayer S; Wernly B; Schwenoha L; Huber-Schönauer U; Stickel F; Niederseer D; Aigner E; Datz C
Clin Transl Gastroenterol; 2021 Apr; 12(4):e00326. PubMed ID: 33821832
[TBL] [Abstract][Full Text] [Related]
26. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
[TBL] [Abstract][Full Text] [Related]
27. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
[No Abstract] [Full Text] [Related]
28. Utility of wrist circumference in recognition of metabolic syndrome in overweight and obese South Indian children and adolescents.
Ahilan V; Krishna VG; Prasad HK; Narayanasamy K; Krishnamoorthy N
J Pediatr Endocrinol Metab; 2022 Jan; 35(1):65-71. PubMed ID: 34758245
[TBL] [Abstract][Full Text] [Related]
29. Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study.
Yoshimura Y; Hamaguchi M; Hashimoto Y; Okamura T; Nakanishi N; Obora A; Kojima T; Fukui M
BMC Gastroenterol; 2021 Aug; 21(1):321. PubMed ID: 34372774
[TBL] [Abstract][Full Text] [Related]
30. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
31. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
32. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
Lin CL; Tai CM; Huang JF; Liu CJ; Chen HF; Cheng PN; Chen CY; Peng CY; Wang CC; Weng SH; Tseng TC; Kao JH
J Gastroenterol Hepatol; 2022 Oct; 37(10):1901-1910. PubMed ID: 35790343
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal analysis of risk of non-alcoholic fatty liver disease in adulthood.
Cuthbertson DJ; Brown E; Koskinen J; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
Liver Int; 2019 Jun; 39(6):1147-1154. PubMed ID: 30347485
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of nonalcoholic fatty liver disease using magnetic resonance in obese children and adolescents.
Benetolo PO; Fernandes MIM; Ciampo IRLD; Elias-Junior J; Sawamura R
J Pediatr (Rio J); 2019; 95(1):34-40. PubMed ID: 29438686
[TBL] [Abstract][Full Text] [Related]
35. Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals.
Cho IY; Chang Y; Sung E; Kang JH; Shin H; Wild SH; Byrne CD; Ryu S
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e583-e599. PubMed ID: 33930552
[TBL] [Abstract][Full Text] [Related]
36. Association between metabolically healthy obesity and non-alcoholic fatty liver disease.
Man S; Lv J; Yu C; Deng Y; Yin J; Wang B; Li L; Liu H
Hepatol Int; 2022 Dec; 16(6):1412-1423. PubMed ID: 35987840
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of nonalcoholic fatty liver disease increased with type 2 diabetes mellitus in overweight/obese youth with polycystic ovary syndrome.
Patel-Sanchez N; Perito E; Tsai P; Raymond-Flesch M; Lodish M; Sarkar M
J Pediatr Endocrinol Metab; 2023 May; 36(5):441-446. PubMed ID: 37060356
[TBL] [Abstract][Full Text] [Related]
38. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
Yılmaz Y; Kanı HT; Demirtaş CÖ; Kaya E; Sapmaz AF; Qutranji L; Alkayyali T; Batun KD; Batman M; Toy B; Çiftaslan A
Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138
[TBL] [Abstract][Full Text] [Related]
39. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
Hamaguchi M; Kojima T; Takeda N; Nakagawa T; Taniguchi H; Fujii K; Omatsu T; Nakajima T; Sarui H; Shimazaki M; Kato T; Okuda J; Ida K
Ann Intern Med; 2005 Nov; 143(10):722-8. PubMed ID: 16287793
[TBL] [Abstract][Full Text] [Related]
40. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.
Han E; Lee YH; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Kim SU
Aliment Pharmacol Ther; 2018 Aug; 48(3):300-312. PubMed ID: 29920701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
